Author

E. A. Saada

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Assay:imaging· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. R. Weilhammer· 2 shared A. Ladd· 1 shared A. M. Lillo· 1 shared A. M. Phillips· 1 shared A. T. Zemla· 1 shared B. Dadonaite· 1 shared B. Harmon· 1 shared B. K. Petersen· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. R. Weilhammer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

T. A. Desautels, K. T. Arrildt, A. T. Zemla, E. Y. Lau, F. Zhu, D. Ricci, S. Cronin, S. Zost, E. Binshtein, S. M. Scheaffer, B. Dadonaite, B. K. Petersen, T. B. Engdahl, E. Chen, L. S. Handal, , Carnahan

This paper computationally redesigns an antibody to restore potency against SARS-CoV-2 Omicron subvariants while maintaining efficacy against Delta and other variants.

Nature · May 8, 2024Peer-reviewedMicrobiology

Development of Potent and Effective Synthetic SARS-CoV-2 Neutralizing Nanobodies

M. A. Stefan, Y. K. Light, J. L. Schwedler, P. R. McIlroy, C. M. Courtney, E. A. Saada, C. E. Thatcher, A. M. Phillips, F. A. Bourguet, C. M. Mageeney, S. A. McCloy, N. M. Collette, O. A. Negrete, J. S. Schoeniger, D. R. Weilhammer, B. Harmon

This paper identifies and characterizes potent SARS-CoV-2 neutralizing nanobodies that block viral entry and show efficacy in vivo.

mAbs · Aug 4, 2021Peer-reviewedImmunology

Identification of positive chemotaxis in the protozoan pathogen Trypanosoma brucei

S. F. DeMarco, E. A. Saada, M. A. Lopez, K. L. Hill

This paper identifies positive chemotaxis in Trypanosoma brucei, showing they move toward E. coli colonies, which involves changes in group and single-cell motility.

bioRxiv · Jun 11, 2019Microbiology